How many endoscopies are performed for colorectal cancer screening? Results from CDC’s survey of endoscopic capacity

Seeff, Laura C.; Richards, Thomas B.; Shapiro, Jean A.; Nadel, Marion R.; Manninen, Diane L.; Given, Leslie; Dong, Fred B.; Winges, Linda D.; McKenna, Matthew T.

doi:10.1053/j.gastro.2004.09.051

Cited by 402 publications

(235 citation statements)

References 17 publications

Supporting

Mentioning

232

Contrasting

Unclassified

Order By: Relevance

“…103 Other data from endoscopic facilities across the United States collected and analyzed by investigators from the Centers for Disease Control and Prevention estimated that approximately 2.8 million FSIG examinations and 14.2 million colonoscopy examinations were performed in 2002. 104 Low reimbursement and a shortage of adequately trained examiners are 2 barriers to the availability of FSIG. 30,105 In settings where reimbursement rates have not been a concern and where nurse endoscopists have been employed, high rates of FSIG utilization have been achieved.…”

Section: Fsigmentioning

confidence: 99%

See 1 more Smart Citation

Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology

Levin

Lieberman

McFarland

et al. 2008

CA: A Cancer Journal for Clinicians

1,568

916

View full text Add to dashboard Cite

In the United States, colorectal cancer (CRC) is the third most common cancer diagnosed among men and women and the second leading cause of death from cancer. CRC largely can be prevented by the detection and removal of adenomatous polyps, and survival is significantly better when CRC is diagnosed while still localized. In 2006 to 2007, the American Cancer Society, the US Multi Society Task Force on Colorectal Cancer, and the American College of Radiology came together to develop consensus guidelines for the detection of adenomatous polyps and CRC in asymptomatic average-risk adults. In this update of each organization's guidelines, screening tests are grouped into those that primarily detect cancer early and those that can detect cancer early and also can detect adenomatous polyps, thus providing a greater potential for prevention through polypectomy. When possible, clinicians should make patients aware of the full range of screening options, but at a minimum they should be prepared to offer patients a choice between a screening test that is effective at both early cancer detection and cancer prevention through the detection and removal of polyps and a screening test that primarily is effective at early cancer detection. It is the strong opinion of these 3 organizations that colon cancer prevention should be the primary goal of screening. (CA Cancer J Clin 2008;58:130-160.)

show abstract

Section: Fsigmentioning

confidence: 99%

“…104 Colonoscopy allows direct mucosal inspection of the entire colon from the appendiceal orifice to the dentate line and same-session biopsy sampling or definitive treatment by polypectomy in the case of precancerous polyps and some early-stage cancers.…”

Section: Colonoscopymentioning

confidence: 99%

Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology

Levin

Lieberman

McFarland

et al. 2008

CA: A Cancer Journal for Clinicians

1,568

916

View full text Add to dashboard Cite

show abstract

“…1 Bowel preparation is usually achieved using either polyethylene glycol or oral sodium phosphosoda (OPS). In many cases, OPS is the preferred bowel regimen on the basis of better tolerability, cost-effectiveness, and efficacy.…”

mentioning

confidence: 99%

Risk of Kidney Injury Following Oral Phosphosoda Bowel Preparations

Brunelli¹,

Lewis²,

Gupta³

et al. 2007

Journal of the American Society of Nephrology

View full text Add to dashboard Cite

Case reports and case series suggest a potential link between oral sodium phosphosoda used in preparation for outpatient colonoscopy and kidney injury, but controlled studies are lacking. We performed a case-control study nested within a cohort of patients with baseline serum creatinine Յ1.5 mg/dL who underwent outpatient colonoscopy. We defined a case of kidney injury as a rise in serum creatinine Ն0.5 mg/dL and/or 25% between values obtained during the 6 months prior and during the 6 months following colonoscopy (n ϭ 116). We found that exposure to phosphosoda was not more common among patients with incident kidney injury (adjusted odds ratio 0.70; 95% CI 0.44 -1.11), and sensitivity analyses that considered other definitions of kidney injury did not suggest a different conclusion. Therefore, despite a plausible link, the current data do not support an association between oral phosphosoda and kidney injury at 6 months follow-up among patients with baseline serum creatinine Յ1.5 mg/dL. Further studies are warranted to validate and generalize our findings.

show abstract

“…It is widely used in the United Stated, especially since 2001, when Medicare expanded its coverage for screening for colorectal cancer to include colonoscopy. An estimated 14.2 million colonoscopies were performed in 2002 in the United States, with screening indications representing half of cases [1]. Although generally considered a safe procedure, complications of colonoscopy as an invasive procedure should be noted.…”

Section: Introductionmentioning

confidence: 99%